Thursday, June 23, 2011

High Yield Big Pharmaceutical Stocks

Between 1945 and 1964, seventy-six million American babies were born, making up what is now known as the Baby Boomers. The Boomers buy 77% of all prescription drugs and 61% of over-the-counter medications.

Many income investors are looking for dividend stocks in the health care sector due to the increasing age of the Baby Boomers and their parents. These include the major drug manufacturers, the generic drug manufacturers, diagnostic companies, healthcare plans, hospitals, medical appliances, medical instruments, and medical laboratories.

Based on the free list of high yield big pharmaceutical stocks at, there are ten pharmaceutical stocks with yields of 1.5% or more, with two stocks paying more than 5%. One example is GlaxoSmithKline plc (GSK), the third largest pharmaceutical company in the world by revenues, after Johnson & Johnson (JNJ) and Pfizer(PFE). Glaxo's products include Aquafresh, Boniva, Dexedrine, Levitra, Nicoderm, Nicorette, Sensodyne, Tums, and Valtrex. The stock pays a generous yield of 5.1% payable quarterly. It trades at 10.5 times forward earnings. Although sales were down for the latest quarter, earnings were up 13.8% year over year.

Johnson & Johnson (JNJ), the world's largest pharma company, is a manufacturer of pharmaceutical, medical devices and consumer packaged goods. The company, which was founded in 1886, yields 3.4% and has a forward price to earnings ratio of 12.4. Revenues for the latest quarter were up 3.4% but earnings were down 23.2%.

Merck & Co., Inc. (MRK), another big pharmaceutical, yields 4.2% and trades at 9.1 times forward earnings. Earnings for the latest quarter were up almost 250% on flat revenues.

If you want a list of other high yield pharma stocks, that can be downloaded and sorted, go to

Disclosure: Author owns PFE.


No comments: